TY - JOUR AU - Jemal, A. AU - Bray, F. AU - Center, M. M. AU - Ferlay, J. AU - Ward, E. AU - Forman, D. PY - 2011 DA - 2011// TI - Global cancer statistics JO - CA Cancer J Clin VL - 61 UR - https://doi.org/10.3322/caac.20107 DO - 10.3322/caac.20107 ID - Jemal2011 ER - TY - JOUR AU - Coleman, M. P. AU - Forman, D. AU - Bryant, H. AU - Butler, J. AU - Rachet, B. AU - Maringe, C. PY - 2011 DA - 2011// TI - Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data JO - Lancet VL - 377 UR - https://doi.org/10.1016/S0140-6736(10)62231-3 DO - 10.1016/S0140-6736(10)62231-3 ID - Coleman2011 ER - TY - JOUR AU - Kipps, E. AU - Tan, D. S. P. AU - Kaye, S. B. PY - 2013 DA - 2013// TI - Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research JO - Nat Rev Cancer VL - 13 UR - https://doi.org/10.1038/nrc3432 DO - 10.1038/nrc3432 ID - Kipps2013 ER - TY - JOUR AU - Lengyel, E. PY - 2010 DA - 2010// TI - Ovarian cancer development and metastasis JO - Am J Pathol VL - 177 UR - https://doi.org/10.2353/ajpath.2010.100105 DO - 10.2353/ajpath.2010.100105 ID - Lengyel2010 ER - TY - JOUR AU - Shield, K. AU - Ackland, M. L. AU - Ahmed, N. AU - Rice, G. E. PY - 2009 DA - 2009// TI - Multicellular spheroids in ovarian cancer metastases: biology and pathology JO - Gynecol Oncol VL - 113 UR - https://doi.org/10.1016/j.ygyno.2008.11.032 DO - 10.1016/j.ygyno.2008.11.032 ID - Shield2009 ER - TY - JOUR AU - Ali, A. Y. AU - Farrand, L. AU - Kim, J. Y. AU - Byun, S. AU - Suh, J. Y. AU - Lee, H. J. PY - 2012 DA - 2012// TI - Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum JO - Ann N Y Acad Sci VL - 1271 UR - https://doi.org/10.1111/j.1749-6632.2012.06734.x DO - 10.1111/j.1749-6632.2012.06734.x ID - Ali2012 ER - TY - JOUR AU - Liu, X. AU - Gao, Y. AU - Lu, Y. AU - Zhang, J. AU - Li, L. AU - Yin, F. PY - 2014 DA - 2014// TI - Oncogenes associated with drug resistance in ovarian cancer JO - J Cancer Res Clin Oncol VL - 141 UR - https://doi.org/10.1007/s00432-014-1765-5 DO - 10.1007/s00432-014-1765-5 ID - Liu2014 ER - TY - JOUR AU - Ward, R. J. AU - Dirks, P. B. PY - 2007 DA - 2007// TI - Cancer stem cells: at the headwaters of tumor development JO - Annu Rev Pathol VL - 2 UR - https://doi.org/10.1146/annurev.pathol.2.010506.091847 DO - 10.1146/annurev.pathol.2.010506.091847 ID - Ward2007 ER - TY - JOUR AU - Hermann, P. C. AU - Huber, S. L. AU - Herrler, T. AU - Aicher, A. AU - Ellwart, J. W. AU - Guba, M. PY - 2007 DA - 2007// TI - Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer JO - Cell Stem Cell VL - 1 UR - https://doi.org/10.1016/j.stem.2007.06.002 DO - 10.1016/j.stem.2007.06.002 ID - Hermann2007 ER - TY - JOUR AU - Castillo, V. AU - Valenzuela, R. AU - Huidobro, C. AU - Contreras, H. R. AU - Castellon, E. A. PY - 2014 DA - 2014// TI - Functional characteristics of cancer stem cells and their role in drug resistance of prostate cancer JO - Int J Oncol VL - 45 ID - Castillo2014 ER - TY - JOUR AU - Hashimoto, N. AU - Tsunedomi, R. AU - Yoshimura, K. AU - Watanabe, Y. AU - Hazama, S. AU - Oka, M. PY - 2014 DA - 2014// TI - Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs JO - BMC Cancer VL - 14 UR - https://doi.org/10.1186/1471-2407-14-722 DO - 10.1186/1471-2407-14-722 ID - Hashimoto2014 ER - TY - JOUR AU - Zhang, Q. H. AU - Dou, H. T. AU - Xu, P. AU - Zhuang, S. C. AU - Liu, P. S. PY - 2014 DA - 2014// TI - Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer JO - Drug Res VL - 65 UR - https://doi.org/10.1055/s-0034-1375609 DO - 10.1055/s-0034-1375609 ID - Zhang2014 ER - TY - JOUR AU - Latifi, A. AU - Abubaker, K. AU - Castrechini, N. AU - Ward, A. C. AU - Liongue, C. AU - Dobill, F. PY - 2011 DA - 2011// TI - Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile JO - J Cell Biochem VL - 112 UR - https://doi.org/10.1002/jcb.23199 DO - 10.1002/jcb.23199 ID - Latifi2011 ER - TY - JOUR AU - Latifi, A. AU - Luwor, R. B. AU - Bilandzic, M. AU - Nazaretian, S. AU - Stenvers, K. AU - Pyman, J. PY - 2012 DA - 2012// TI - Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors JO - Plos One VL - 7 UR - https://doi.org/10.1371/journal.pone.0046858 DO - 10.1371/journal.pone.0046858 ID - Latifi2012 ER - TY - JOUR AU - Abubaker, K. AU - Latifi, A. AU - Luwor, R. AU - Nazaretian, S. AU - Zhu, H. AU - Quinn, M. A. PY - 2013 DA - 2013// TI - Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden JO - Mol Cancer VL - 12 UR - https://doi.org/10.1186/1476-4598-12-24 DO - 10.1186/1476-4598-12-24 ID - Abubaker2013 ER - TY - JOUR AU - Hu, L. AU - McArthur, C. AU - Jaffe, R. B. PY - 2010 DA - 2010// TI - Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant JO - Br J Cancer VL - 102 UR - https://doi.org/10.1038/sj.bjc.6605626 DO - 10.1038/sj.bjc.6605626 ID - Hu2010 ER - TY - JOUR AU - Steg, A. D. AU - Bevis, K. S. AU - Katre, A. A. AU - Ziebarth, A. AU - Dobbin, Z. C. AU - Alvarez, R. D. PY - 2012 DA - 2012// TI - Stem cell pathways contribute to clinical chemoresistance in ovarian cancer JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-2188 DO - 10.1158/1078-0432.CCR-11-2188 ID - Steg2012 ER - TY - JOUR AU - Chen, K. AU - Huang, Y. -. h. AU - Chen, J. -. l. PY - 2013 DA - 2013// TI - Understanding and targeting cancer stem cells: therapeutic implications and challenges JO - Acta Pharmacol Sin VL - 34 UR - https://doi.org/10.1038/aps.2013.27 DO - 10.1038/aps.2013.27 ID - Chen2013 ER - TY - JOUR AU - Maccalli, C. AU - Maria, R. PY - 2014 DA - 2014// TI - Cancer stem cells: perspectives for therapeutic targeting JO - Cancer Immunol Immunother VL - 64 UR - https://doi.org/10.1007/s00262-014-1592-1 DO - 10.1007/s00262-014-1592-1 ID - Maccalli2014 ER - TY - JOUR AU - Abubaker, K. AU - Luwor, R. B. AU - Escalona, R. AU - McNally, O. AU - Quinn, M. A. AU - Thompson, E. W. PY - 2014 DA - 2014// TI - Targeted disruption of the JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem cells leading to a reduced tumor burden JO - Frontiers In Oncol VL - 4 UR - https://doi.org/10.3389/fonc.2014.00075 DO - 10.3389/fonc.2014.00075 ID - Abubaker2014 ER - TY - JOUR AU - Karoubi, G. AU - Gugger, M. AU - Schmid, R. AU - Dutly, A. PY - 2009 DA - 2009// TI - OCT4 expression in human non-small cell lung cancer: implications for therapeutic intervention JO - Interact Cardiovasc Thorac Surg VL - 8 UR - https://doi.org/10.1510/icvts.2008.193995 DO - 10.1510/icvts.2008.193995 ID - Karoubi2009 ER - TY - JOUR AU - Guo, Y. AU - Liu, S. AU - Wang, P. AU - Zhao, S. AU - Wang, F. AU - Bing, L. PY - 2011 DA - 2011// TI - Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas JO - Histopathology VL - 59 UR - https://doi.org/10.1111/j.1365-2559.2011.03993.x DO - 10.1111/j.1365-2559.2011.03993.x ID - Guo2011 ER - TY - JOUR AU - Liu, C. AU - Cao, X. AU - Zhang, Y. AU - Xu, H. AU - Zhang, R. AU - Wu, Y. PY - 2012 DA - 2012// TI - Co-expression of Oct-4 and Nestin in human breast cancers JO - Mol Biol Rep VL - 39 UR - https://doi.org/10.1007/s11033-011-1398-6 DO - 10.1007/s11033-011-1398-6 ID - Liu2012 ER - TY - JOUR AU - Huang, Z. -. J. AU - You, J. AU - Luo, W. Y. AU - Chen, B. S. AU - Feng, Q. Z. AU - Wu, B. L. PY - 2015 DA - 2015// TI - Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells JO - Mol Med Reports VL - 11 ID - Huang2015 ER - TY - JOUR AU - Koo, B. S. AU - Lee, S. H. AU - Kim, J. M. AU - Huang, S. AU - Kim, S. H. AU - Rho, Y. S. PY - 2014 DA - 2014// TI - Oct4 is a critical regulator of stemness in head and neck squamous carcinoma cells JO - Oncogene VL - 34 UR - https://doi.org/10.1038/onc.2014.174 DO - 10.1038/onc.2014.174 ID - Koo2014 ER - TY - JOUR AU - Wang, X. Q. AU - Ongkeko, W. M. AU - Chen, L. AU - Yang, Z. F. AU - Lu, P. AU - Chen, K. K. PY - 2010 DA - 2010// TI - Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway JO - Hepatol VL - 52 UR - https://doi.org/10.1002/hep.23692 DO - 10.1002/hep.23692 ID - Wang2010 ER - TY - JOUR AU - Hansis, C. AU - Grifo, J. A. AU - Krey, L. C. PY - 2000 DA - 2000// TI - Oct-4 expression in inner cell mass and trophectoderm of human blastocysts JO - Mol Hum Reprod VL - 6 UR - https://doi.org/10.1093/molehr/6.11.999 DO - 10.1093/molehr/6.11.999 ID - Hansis2000 ER - TY - JOUR AU - Wu, G. AU - Schöler, H. R. PY - 2014 DA - 2014// TI - Role of Oct4 in the early embryo development JO - Cell Regeneration VL - 3 UR - https://doi.org/10.1186/2045-9769-3-7 DO - 10.1186/2045-9769-3-7 ID - Wu2014 ER - TY - JOUR AU - Radzisheuskaya, A. AU - Chia Gle, B. AU - Dos Santos, R. L. AU - Theunissen, T. W. AU - Castro, L. F. AU - Nichols, J. PY - 2013 DA - 2013// TI - A defined Oct4 level governs cell state transitions of pluripotency entry and differentiation into all embryonic lineages JO - Nat Cell Biol VL - 15 UR - https://doi.org/10.1038/ncb2742 DO - 10.1038/ncb2742 ID - Radzisheuskaya2013 ER - TY - JOUR AU - Wang, X. AU - Dai, J. PY - 2010 DA - 2010// TI - Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology JO - Stem Cells VL - 28 ID - Wang2010 ER - TY - JOUR AU - Lee, J. AU - Kim, H. K. AU - Rho, J. Y. AU - Han, Y. M. AU - Kim, J. PY - 2006 DA - 2006// TI - The human OCT-4 isoforms differ in their ability to confer self-renewal JO - J Biol Chem VL - 281 UR - https://doi.org/10.1074/jbc.M603937200 DO - 10.1074/jbc.M603937200 ID - Lee2006 ER - TY - JOUR AU - Atlasi, Y. AU - Mowla, S. J. AU - Ziaee, S. A. AU - Gokhale, P. J. AU - Andrews, P. W. PY - 2008 DA - 2008// TI - OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells JO - Stem Cells VL - 26 UR - https://doi.org/10.1634/stemcells.2008-0530 DO - 10.1634/stemcells.2008-0530 ID - Atlasi2008 ER - TY - JOUR AU - Zhao, S. AU - Yuan, Q. AU - Hao, H. AU - Guo, Y. AU - Liu, S. AU - Zhang, Y. PY - 2011 DA - 2011// TI - Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma JO - J Pathol VL - 223 UR - https://doi.org/10.1002/path.2827 DO - 10.1002/path.2827 ID - Zhao2011 ER - TY - JOUR AU - Sodek, K. L. AU - Ringuette, M. J. AU - Brown, T. J. PY - 2009 DA - 2009// TI - Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype JO - Int J Cancer VL - 124 UR - https://doi.org/10.1002/ijc.24188 DO - 10.1002/ijc.24188 ID - Sodek2009 ER - TY - JOUR AU - Zhang, S. AU - Balch, C. AU - Chan, M. W. AU - Lai, H. C. AU - Matei, D. AU - Schilder, J. M. PY - 2008 DA - 2008// TI - Identification and characterization of ovarian cancer-initiating cells from primary human tumors JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-08-0364 DO - 10.1158/0008-5472.CAN-08-0364 ID - Zhang2008 ER - TY - JOUR AU - Liao, J. AU - Qian, F. AU - Tchabo, N. AU - Mhawech-Fauceglia, P. AU - Beck, A. AU - Qian, Z. PY - 2014 DA - 2014// TI - Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism JO - Plos One VL - 9 UR - https://doi.org/10.1371/journal.pone.0084941 DO - 10.1371/journal.pone.0084941 ID - Liao2014 ER - TY - JOUR AU - Burleson, K. M. AU - Casey, R. C. AU - Skubitz, K. M. AU - Pambuccian, S. E. AU - Oegema, T. R. AU - Skubitz, A. P. PY - 2004 DA - 2004// TI - Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers JO - Gynecol Oncol VL - 93 UR - https://doi.org/10.1016/j.ygyno.2003.12.034 DO - 10.1016/j.ygyno.2003.12.034 ID - Burleson2004 ER - TY - JOUR AU - Burleson, K. M. AU - Boente, M. P. AU - Pambuccian, S. E. AU - Skubitz, A. P. PY - 2006 DA - 2006// TI - Disaggregation and invasion of ovarian carcinoma ascites spheroids JO - J Transl Med VL - 4 UR - https://doi.org/10.1186/1479-5876-4-6 DO - 10.1186/1479-5876-4-6 ID - Burleson2006 ER - TY - JOUR AU - Ween, M. P. AU - Oehler, M. K. AU - Ricciardelli, C. PY - 2011 DA - 2011// TI - Role of versican, hyaluronan and CD44 in ovarian cancer metastasis JO - Int J Mole Scie VL - 12 UR - https://doi.org/10.3390/ijms12021009 DO - 10.3390/ijms12021009 ID - Ween2011 ER - TY - JOUR AU - Takaishi, S. AU - Okumura, T. AU - Tu, S. AU - Wang, S. S. AU - Shibata, W. AU - Vigneshwaran, R. PY - 2009 DA - 2009// TI - Identification of gastric cancer stem cells using the cell surface marker CD44 JO - Stem Cells VL - 27 UR - https://doi.org/10.1002/stem.30 DO - 10.1002/stem.30 ID - Takaishi2009 ER - TY - JOUR AU - Yamashita, T. AU - Ji, J. AU - Budhu, A. AU - Forgues, M. AU - Yang, W. AU - Wang, H. Y. PY - 2009 DA - 2009// TI - EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features JO - Gastroenterology VL - 136 UR - https://doi.org/10.1053/j.gastro.2008.12.004 DO - 10.1053/j.gastro.2008.12.004 ID - Yamashita2009 ER - TY - JOUR AU - Wells, A. AU - Grahovac, J. AU - Wheeler, S. AU - Ma, B. AU - Lauffenburger, D. PY - 2013 DA - 2013// TI - Targeting tumor cell motility as a strategy against invasion and metastasis JO - Trends Pharmacol Sci VL - 34 UR - https://doi.org/10.1016/j.tips.2013.03.001 DO - 10.1016/j.tips.2013.03.001 ID - Wells2013 ER - TY - JOUR AU - Kalogeraki, A. AU - Karvela-Kalogeraki, I. AU - Petraki, P. E. AU - Zois, I. AU - Tamiolakis, D. AU - Stathopoulos, E. N. PY - 2011 DA - 2011// TI - Apoptosis and cell proliferation correlated with tumour grade in peritoneal fluids of patients with serous ovarian cancer JO - Cytopathology VL - 22 UR - https://doi.org/10.1111/j.1365-2303.2010.00797.x DO - 10.1111/j.1365-2303.2010.00797.x ID - Kalogeraki2011 ER - TY - JOUR AU - Agarwal, R. AU - Kaye, S. B. PY - 2003 DA - 2003// TI - Ovarian cancer: strategies for overcoming resistance to chemotherapy JO - Nat Rev Cancer VL - 3 UR - https://doi.org/10.1038/nrc1123 DO - 10.1038/nrc1123 ID - Agarwal2003 ER - TY - JOUR AU - Schoenhals, M. AU - Kassambara, A. AU - Vos, J. AU - Hose, D. AU - Moreaux, J. AU - Klein, B. PY - 2009 DA - 2009// TI - Embryonic stem cell markers expression in cancers JO - Biochem Biophys Res Commun VL - 383 UR - https://doi.org/10.1016/j.bbrc.2009.02.156 DO - 10.1016/j.bbrc.2009.02.156 ID - Schoenhals2009 ER - TY - JOUR AU - Samardzija, C. AU - Quinn, M. AU - Findlay, J. K. AU - Ahmed, N. PY - 2012 DA - 2012// TI - Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary JO - J Ovarian Res VL - 5 UR - https://doi.org/10.1186/1757-2215-5-37 DO - 10.1186/1757-2215-5-37 ID - Samardzija2012 ER - TY - JOUR AU - Di, J. AU - Duiveman-de Boer, T. AU - Zusterzeel, P. L. AU - Figdor, C. G. AU - Massuger, L. F. AU - Torensma, R. PY - 2013 DA - 2013// TI - The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients JO - Cell Oncol VL - 36 UR - https://doi.org/10.1007/s13402-013-0142-8 DO - 10.1007/s13402-013-0142-8 ID - Di2013 ER - TY - JOUR AU - Shaw, T. J. AU - Senterman, M. K. AU - Dawson, K. AU - Crane, C. A. AU - Vanderhyden, B. C. PY - 2004 DA - 2004// TI - Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer JO - Mol Ther VL - 10 UR - https://doi.org/10.1016/j.ymthe.2004.08.013 DO - 10.1016/j.ymthe.2004.08.013 ID - Shaw2004 ER - TY - JOUR AU - Bapat, S. A. AU - Mali, A. M. AU - Koppikar, C. B. AU - Kurrey, N. K. PY - 2005 DA - 2005// TI - Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer JO - Cancer Res VL - 65 ID - Bapat2005 ER - TY - JOUR AU - Vathipadiekal, V. AU - Saxena, D. AU - Mok, S. C. AU - Hauschka, P. V. AU - Ozbun, L. AU - Birrer, M. J. PY - 2012 DA - 2012// TI - Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer JO - Plos One VL - 7 UR - https://doi.org/10.1371/journal.pone.0029079 DO - 10.1371/journal.pone.0029079 ID - Vathipadiekal2012 ER - TY - JOUR AU - Copley, M. R. AU - Babovic, S. AU - Benz, C. AU - Knapp, D. J. AU - Beer, P. A. AU - Kent, D. G. PY - 2013 DA - 2013// TI - The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells JO - Nat Cell Biol VL - 15 UR - https://doi.org/10.1038/ncb2783 DO - 10.1038/ncb2783 ID - Copley2013 ER - TY - JOUR AU - Fong, H. AU - Hohenstein, K. A. AU - Donovan, P. J. PY - 2008 DA - 2008// TI - Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells JO - Stem Cells VL - 26 UR - https://doi.org/10.1634/stemcells.2007-1002 DO - 10.1634/stemcells.2007-1002 ID - Fong2008 ER - TY - JOUR AU - Bourguignon, L. Y. AU - Wong, G. AU - Earle, C. AU - Chen, L. PY - 2012 DA - 2012// TI - Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma JO - J Biol Chem VL - 287 UR - https://doi.org/10.1074/jbc.M111.308528 DO - 10.1074/jbc.M111.308528 ID - Bourguignon2012 ER - TY - JOUR AU - Spizzo, G. AU - Went, P. AU - Dirnhofer, S. AU - Obrist, P. AU - Moch, H. AU - Baeuerle, P. A. PY - 2006 DA - 2006// TI - Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer JO - Gynecol Oncol VL - 103 UR - https://doi.org/10.1016/j.ygyno.2006.03.035 DO - 10.1016/j.ygyno.2006.03.035 ID - Spizzo2006 ER - TY - JOUR AU - Anttila, M. A. AU - Tammi, R. H. AU - Tammi, M. I. AU - Syrjänen, K. J. AU - Saarikoski, S. V. AU - Kosma, V. M. PY - 2000 DA - 2000// TI - High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer JO - Cancer Res VL - 60 ID - Anttila2000 ER - TY - JOUR AU - Ozols, R. F. PY - 2006 DA - 2006// TI - Systemic therapy for ovarian cancer: current status and new treatments JO - Semin Oncol VL - 33 UR - https://doi.org/10.1053/j.seminoncol.2006.03.011 DO - 10.1053/j.seminoncol.2006.03.011 ID - Ozols2006 ER - TY - JOUR AU - Reers, S. AU - Pfannerstill, A. C. AU - Maushagen, R. AU - Pries, R. AU - Wollenberg, B. PY - 2014 DA - 2014// TI - Stem cell profiling in head and neck cancer reveals an Oct-4 expressing subpopulation with properties of chemoresistance JO - Oral Oncol VL - 50 UR - https://doi.org/10.1016/j.oraloncology.2013.12.006 DO - 10.1016/j.oraloncology.2013.12.006 ID - Reers2014 ER - TY - JOUR AU - Ahmed, N. AU - Riley, C. AU - Oliva, K. AU - Stutt, E. AU - Rice, G. E. AU - Quinn, M. A. PY - 2003 DA - 2003// TI - Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid JO - J Pathol VL - 201 UR - https://doi.org/10.1002/path.1441 DO - 10.1002/path.1441 ID - Ahmed2003 ER - TY - JOUR AU - Wong, A. S. T. AU - Roskelley, C. D. AU - Pelech, S. AU - Miller, D. AU - Leung, P. C. AU - Auersperg, N. PY - 2004 DA - 2004// TI - Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation JO - Exp Cell Res VL - 299 UR - https://doi.org/10.1016/j.yexcr.2004.06.002 DO - 10.1016/j.yexcr.2004.06.002 ID - Wong2004 ER -